Novozymes spinout closes doors after years-long antibiotics effort

The Danish biotech company Adenium Biotech, that focuses on multi-resistant bacteria, has decided to pull the plug and go into voluntary liquidation.

Photo: Peter Klint / Ritzau Scanpix

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles